MARKET

MEIP

MEIP

Mei Pharma Inc
NASDAQ
2.940
+0.250
+9.29%
After Hours: 3.050 +0.11 +3.74% 19:47 07/14 EDT
OPEN
2.640
PREV CLOSE
2.690
HIGH
2.940
LOW
2.640
VOLUME
125.52K
TURNOVER
--
52 WEEK HIGH
4.100
52 WEEK LOW
1.460
MARKET CAP
19.59M
P/E (TTM)
-0.6187
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MEIP last week (0707-0711)?
Weekly Report · 18h ago
Weekly Report: what happened at MEIP last week (0630-0704)?
Weekly Report · 07/07 09:46
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 06/30 12:08
Weekly Report: what happened at MEIP last week (0623-0627)?
Weekly Report · 06/30 09:48
Weekly Report: what happened at MEIP last week (0616-0620)?
Weekly Report · 06/23 09:45
Weekly Report: what happened at MEIP last week (0609-0613)?
Weekly Report · 06/16 09:48
Weekly Report: what happened at MEIP last week (0602-0606)?
Weekly Report · 06/09 09:48
Weekly Report: what happened at MEIP last week (0526-0530)?
Weekly Report · 06/02 09:51
More
About MEIP
MEI Pharma, Inc. is a pharmaceutical company, which is engaged in developing cancer therapies. The Company’s pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor. Voruciclib has completed a Phase I trial evaluating dose and schedule in patients with acute myeloid leukemia (AML) in combination with the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax (marketed as Venclexta). Voruciclib is also being evaluated in pre-clinical studies to explore potential activity in various solid tumor cancers including in combination with therapies that target the RAS signaling pathway, such as KRAS inhibitors. CDK9 has functions in cell cycle regulation, including the modulation of two therapeutic targets in cancer: myeloid leukemia cell differentiation protein (MCL1) and the MYC proto-oncogene protein (MYC) which regulates cell proliferation and growth.

Webull offers MEI Pharma Inc stock information, including NASDAQ: MEIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEIP stock methods without spending real money on the virtual paper trading platform.